← Back to Search

Virtual Reality Technology for Head and Neck Cancer

N/A
Recruiting
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with head and neck squamous cell carcinoma of the mucosa
Age > 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the time from completion of treatment to marginal recurrence of tumor at the primary site, assessed up to 3 years
Awards & highlights

Study Summary

This trial uses virtual reality technology and 3D-surgery modeling to improve current treatments for head and neck cancer. This may improve surgical planning and communication between surgeons and pathologists, and ultimately increase the accuracy of planning and quality of communication for patients with head and neck cancer.

Who is the study for?
This trial is for adults over 18 with head and neck squamous cell carcinoma, treated at Thomas Jefferson University by a specialized surgeon. Participants must be able to consent. Those with impaired judgment or other risks that affect study compliance or those in another clinical trial can't join.Check my eligibility
What is being tested?
The study tests virtual reality technology and 3D-surgery modeling as tools to improve surgical planning and team communication in treating head and neck cancer, aiming to enhance the precision of surgery plans and patient outcomes.See study design
What are the potential side effects?
Since this trial involves non-invasive technology for planning rather than direct treatment, traditional side effects are not expected; however, participants may experience discomfort from VR equipment or anxiety related to surgery visualization.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a type of throat cancer.
Select...
I am older than 18 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the time from completion of treatment to marginal recurrence of tumor at the primary site, assessed up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and the time from completion of treatment to marginal recurrence of tumor at the primary site, assessed up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Margin events
Secondary outcome measures
Event free survival

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (VR/3D-CEPs, standard treatment)Experimental Treatment3 Interventions
Prior to surgery (day 0-13), patients undergo virtual reality 3D tumor resection via VR/3D-CEPs. Patients' pre-surgical CT scans are reviewed per standard of care. Patients then undergo surgical resection on day 14-29 and a 3D model of true tumor is created and imported into the virtual reality environment.
Group II: Arm II (standard treatment)Active Control2 Interventions
Prior to surgery (day 0-13), patients' pre-surgical CT scans are reviewed per standard of care. Patients then undergo surgical resection on day 14-29.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resection
2021
Completed Phase 2
~410

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
443 Previous Clinical Trials
145,340 Total Patients Enrolled

Media Library

Resection Clinical Trial Eligibility Overview. Trial Name: NCT05031910 — N/A
Head and Neck Squamous Cell Carcinoma Research Study Groups: Arm I (VR/3D-CEPs, standard treatment), Arm II (standard treatment)
Head and Neck Squamous Cell Carcinoma Clinical Trial 2023: Resection Highlights & Side Effects. Trial Name: NCT05031910 — N/A
Resection 2023 Treatment Timeline for Medical Study. Trial Name: NCT05031910 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the population size of this experiment?

"Affirmative, clinicaltrials.gov indicates that this trial is currently recruiting patients. It was first posted on February 4th 2022 and last updated on August 1st 2022 - it seeks to enroll 40 individuals from one site."

Answered by AI

Are researchers currently seeking volunteers for this trial?

"Affirmative. Per the information provided via clinicaltrials.gov, this medical experiment is still recruiting participants after its initial posting on February 4th 2022 and last update on August 1st 2022. The team aims to enrol 40 patients from a single site."

Answered by AI
~86 spots leftby Sep 2026